PlainRecalls
FDA Drug Moderate Class II Terminated

Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.

Reported: March 24, 2021 Initiated: March 11, 2021 #D-0305-2021

Product Description

Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.

Reason for Recall

Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.

Details

Units Affected
3716 cartons
Distribution
Nationwide in the USA and Puerto Rico
Location
Schaumburg, IL

Frequently Asked Questions

What product was recalled?
Phenylephrine HCl Injection, USP, 10 mg per mL, 1 mL per Single-Dose Vial packaged in 25 x 1 mL Single-Dose Vials per carton, For Intravenous Use, Rx only, Mfd. for: SAGENT Pharmaceuticals, Schaumburg, IL 60195; Made in India, NDC: 25021-315-01.. Recalled by Sagent Pharmaceuticals Inc. Units affected: 3716 cartons.
Why was this product recalled?
Lack of Assurance of Sterility: customer complaints of loose crimped vial overseals which may result in a non-sterile product.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 24, 2021. Severity: Moderate. Recall number: D-0305-2021.